(Total Views: 577)
Posted On: 10/20/2020 7:47:44 AM
Post# of 154410
Re: generactor #62124
That EUA is based on risk/benefit analysis and leronlimab has an excellent safety profile and the benefit side is "may have some benefit" than leronlimab should be easily EUA approved based on those criteria.
(5)
(0)
